World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
50492
World Ranking
9489
National Ranking
520

Overview

Christian Peschel is affiliated with the Technical University of Munich in Germany and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields including Immunology, Molecular Biology, Hematology, Oncology, and Cancer Research.

The scientist's work highlights a focus on themes such as Immunotherapy and Immune Responses, Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Toxin Mechanisms and Immunotoxins, Wnt/β-catenin signaling in development and cancer, Epigenetics and DNA Methylation, and Fibroblast Growth Factor Research.

Christian Peschel has coauthored multiple papers with recurring collaborators, including Rouzanna Istvánffy, Robert A.J. Oostendorp, Franziska Hettler, Christina Schreck, and Sandra Romero Marquez.

Recent publications by Christian Peschel include:

  • MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial (2020, The Lancet Haematology)
  • Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure (2020, Journal of Clinical Investigation)
  • Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300 (2022, Haematologica)
  • Cathepsin K maintains the compartment of bone marrow T lymphocytes in vivo (2021, Immunity Inflammation and Disease)
  • Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST) (2023, International Journal of Molecular Sciences)

Christian Peschel's research has appeared in various scientific journals including The Lancet Haematology, Haematologica, Journal of Clinical Investigation, Immunity Inflammation and Disease, and the International Journal of Molecular Sciences.

Best Publications

  • Improved Survival with Ipilimumab in Patients with Metastatic Melanoma.

    F. Stephen Hodi;Steven J. O'Day;David F. McDermott;Robert W. Weber

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

    Olaf Gross;Andreas Gewies;Katrin Finger;Martin Schäfer

  • PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

    Florian Lordick;Katja Ott;Bernd-Joachim Krause;Wolfgang A Weber

  • Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

    Axel Hauschild;Sanjiv S. Agarwala;Uwe Trefzer;David Hogg

  • Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

    Michal Bassani-Sternberg;Eva Bräunlein;Richard Klar;Thomas Engleitner;Thomas Engleitner

  • BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

    Nikolas von Bubnoff;Folker Schneller;Christian Peschel;Justus Duyster

  • Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1|[beta]| production

    Hendrik Poeck;Michael Bscheider;Olaf Gross;Olaf Gross;Katrin Finger

  • Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

    R. Gralla;M. Lichinitser;S. Van der Vegt;H. Sleeboom

  • Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use

    Wolfgang A. Weber;Volker Petersen;Burkhard Schmidt;Leishia Tyndale-Hines

  • Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    R. Zeiser;A. Burchert;C. Lengerke;M.M. Verbeek

  • A bioactive designer cytokine for human hematopoietic progenitor cell expansion

    Martina Fischer;Jutta Goldschmitt;Christian Peschel;Just P. G. Brakenhoff

  • Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

    M. Dank;J. Zaluski;C. Barone;V. Valvere

  • Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

    Silvia Spoerl;Nimitha R. Mathew;Michael Bscheider;Annette Schmitt-Graeff

  • Rituximab therapy of patients with B-cell chronic lymphocytic leukemia.

    Dieter Huhn;Christoph von Schilling;Martin Wilhelm;Anthony D. Ho

  • Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity

    Ren Yuan Bai;Peter Dieter;Christian Peschel;Stephan W. Morris

  • The Ubiquitin Ligase XIAP Recruits LUBAC for NOD2 Signaling in Inflammation and Innate Immunity

    Rune Busk Damgaard;Ueli Nachbur;Ueli Nachbur;Ueli Nachbur;Monica Yabal;Wendy Wei-Lynn Wong;Wendy Wei-Lynn Wong

  • Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

    Ingo Ringshausen;Folker Schneller;Christian Bogner;Susanne Hipp

  • Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells

    Thomas Decker;Folker Schneller;Tim Sparwasser;Theresa Tretter

  • Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

    S. Lorenzen;T. Schuster;R. Porschen;S.-E. Al-Batran

Frequent Co-Authors

Markus Schwaiger
Markus Schwaiger Technical University of Munich
Jürgen Ruland
Jürgen Ruland Technical University of Munich
Florian Lordick
Florian Lordick Leipzig University
Ken Herrmann
Ken Herrmann German Cancer Research Center
Tibor Schuster
Tibor Schuster McGill University
Hans-Jürgen Wester
Hans-Jürgen Wester Technical University of Munich
Stephan W. Morris
Stephan W. Morris St. Jude Children's Research Hospital
Dirk H. Busch
Dirk H. Busch Technical University of Munich
Hermann Einsele
Hermann Einsele University of Würzburg
Andreas Strasser
Andreas Strasser Walter and Eliza Hall Institute of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine extends far beyond the traditional route to becoming a physician. Many aspiring healthcare professionals look for alternative degrees or accelerated programs that allow them to enter the workforce quickly and make a meaningful impact.

If you’re interested in patient care and seeking a quicker entry point, fast track lpn programs offer flexible online study options to become a Licensed Practical Nurse in less time than traditional paths.

For those who already have a nursing background and want to specialize further, consider the fastest post master's pmhnp online programs to advance your career as a Psychiatric Mental Health Nurse Practitioner.

Interested in healthcare leadership or administration? Affordable online options exist, such as an online health management degree or one of the cheapest online mha programs for a Master’s in Healthcare Administration.

Each of these career pathways offers different advantages and can help you find your place in the dynamic world of healthcare.

Best Scientists Citing Christian Peschel

Trending Scientists

Recently Published Articles